<?xml version="1.0" encoding="UTF-8"?><OAI-PMH
	xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2019-03-02T19:51:34Z</responseDate><request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:3898210" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request><GetRecord><record><header><identifier>oai:pubmedcentral.nih.gov:3898210</identifier><datestamp>2014-01-23</datestamp><setSpec>bmcsb</setSpec><setSpec>pmc-open</setSpec></header><metadata><article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.0/ https://jats.nlm.nih.gov/archiving/1.0/xsd/JATS-archivearticle1.xsd" article-type="research-article" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Struct Biol</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Struct. Biol</journal-id>
      <journal-title-group>
        <journal-title>BMC Structural Biology</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1472-6807</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="accession">PMC3898210</article-id>
      <article-id pub-id-type="pmcid">PMC3898210</article-id>
      <article-id pub-id-type="pmc-uid">3898210</article-id>
      <article-id pub-id-type="pmid">24438169</article-id>
      <article-id pub-id-type="publisher-id">1472-6807-14-3</article-id>
      <article-id pub-id-type="pmid">24438169</article-id>
      <article-id pub-id-type="doi">10.1186/1472-6807-14-3</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Crystal structures of the human Dysferlin inner DysF domain</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" id="A1">
          <name>
            <surname>Sula</surname>
            <given-names>Altin</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>a.sula@mail.cryst.bbk.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A2">
          <name>
            <surname>Cole</surname>
            <given-names>Ambrose R</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>a.cole@mail.cryst.bbk.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A3">
          <name>
            <surname>Yeats</surname>
            <given-names>Corin</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <xref ref-type="aff" rid="I3">3</xref>
          <email>c.yeats@imperial.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" id="A4">
          <name>
            <surname>Orengo</surname>
            <given-names>Christine</given-names>
          </name>
          <xref ref-type="aff" rid="I2">2</xref>
          <email>c.orengo@ucl.ac.uk</email>
        </contrib>
        <contrib contrib-type="author" corresp="yes" id="A5">
          <name>
            <surname>Keep</surname>
            <given-names>Nicholas H</given-names>
          </name>
          <xref ref-type="aff" rid="I1">1</xref>
          <email>n.keep@mail.cryst.bbk.ac.uk</email>
        </contrib>
      </contrib-group>
      <aff id="I1"><label>1</label>Crystallography, Biological Sciences, Institute for Structural and Molecular Biology, Birkbeck University of London, Malet Street, London WC1E 7HX, UK</aff>
      <aff id="I2"><label>2</label>Structural &amp; Molecular Biology, Darwin Building, Institute for Structural and Molecular Biology , University College London, Gower Street, London WC1E 6BT, UK</aff>
      <aff id="I3"><label>3</label>Current Address: Infectious Disease Epidemiology, Imperial College London, St Maryâs Campus, Norfolk Place, London W2 1PG, UK</aff>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>1</month>
        <year>2014</year>
      </pub-date>
      <volume>14</volume>
      <fpage>3</fpage>
      <lpage>3</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>15</day>
          <month>1</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright Â© 2014 Sula et al.; licensee BioMed Central Ltd.</copyright-statement>
        <copyright-year>2014</copyright-year>
        <copyright-holder>Sula et al.; licensee BioMed Central Ltd.</copyright-holder>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <self-uri xlink:href="http://www.biomedcentral.com/1472-6807/14/3"/>
      <abstract>
        <sec>
          <title>Background</title>
          <p>Mutations in dysferlin, the first protein linked with the cell membrane repair mechanism, causes a group of muscular dystrophies called dysferlinopathies. Dysferlin is a type two-anchored membrane protein, with a single C terminal trans-membrane helix, and most of the protein lying in cytoplasm. Dysferlin contains several C2 domains and two DysF domains which are nested one inside the other. Many pathogenic point mutations fall in the DysF domain region.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>We describe the crystal structure of the human dysferlin inner DysF domain with a resolution of 1.9 Ãngstroms. Most of the pathogenic mutations are part of aromatic/arginine stacks that hold the domain in a folded conformation. The high resolution of the structure show that these interactions are a mixture of parallel ring/guanadinium stacking, perpendicular H bond stacking and aliphatic chain packing.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The high resolution structure of the Dysferlin DysF domain gives a template on which to interpret in detail the pathogenic mutations that lead to disease.</p>
        </sec>
      </abstract>
      <kwd-group>
        <kwd>Dysferlin</kwd>
        <kwd>Limb girdle muscular dystrophy 2B</kwd>
        <kwd>Arginine-tryptophan stacking</kwd>
        <kwd>DysF domain</kwd>
        <kwd>Crystal structure</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Dysferlinopathies are a group of autosomal recessive inherited late onset progressive muscular dystrophies caused by malfunction of dysferlin protein. Mutations in the dysferlin protein cause three phenotypes called limb girdle muscular dystrophy type 2B [<xref ref-type="bibr" rid="B1">1</xref>], Miyoshi myopathy [<xref ref-type="bibr" rid="B2">2</xref>], and distal anterior compartment myopathy [<xref ref-type="bibr" rid="B3">3</xref>]. Dysferlin is not a part of the dystrophin-glycoprotein complex, but its function is linked with calcium-activated membrane repair caused by fusing aggregated intracellular vesicles with the sarcolemma at the site of injury [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. The mechanism of membrane repair is not yet determined in detail and the specific role of dysferlin needs to be defined at the structural level.</p>
      <p>Dysferlin, a member of the ferlin protein family, is a type II anchored membrane protein with a single C terminal helix buried in the membrane. Ferlin proteins are defined as containing four or more C2 domains and a C terminal trans-membrane helix. There are 6 ferlin proteins expressed in human; dysferlin, myoferlin, otoferlin, Fer1L4, Fer1L5, and Fer1L6 [<xref ref-type="bibr" rid="B7">7</xref>]. Myoferlin is the most similar paralogue to dysferlin. Both proteins are predicted to have the same domain composition with overall sequence identity of 56%. Dysferlin is expressed in most tissues but is found in abundance in skeletal muscle, heart, brain and placenta.</p>
      <p>The multiple domain architecture of dysferlin was analysed by a combination of Gene3D [<xref ref-type="bibr" rid="B8">8</xref>], SMART [<xref ref-type="bibr" rid="B9">9</xref>] and Pfam [<xref ref-type="bibr" rid="B10">10</xref>] domain family resources. The domain architecture is predicted to consist of seven C2 domains (C2A to C2G), three Fer domains (FerA, FerB and FerI), two DysF domains, one nested inside the other, and a C terminal trans-membrane domain (FigureÂ <xref ref-type="fig" rid="F1">1</xref>a). C2 domains are found in hundreds of proteins and many are known to bind to phospholipids or proteins, often in a calcium dependent manner [<xref ref-type="bibr" rid="B6">6</xref>]. In dysferlin and myoferlin C2A binds to phospholipids in a calcium dependent manner. [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. The other C2 domains do not show calcium-dependent binding to lipids, but do show some calcium independent binding to phospholipids [<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B12">12</xref>]. The other C2 domains are believed to interact with dysferlin binding proteins or to be involved in dimerisation [<xref ref-type="bibr" rid="B13">13</xref>]. Recently it has been shown that there is a minor variant of the dysferlin C2A domain, C2Av1, that does not bind via calcium [<xref ref-type="bibr" rid="B14">14</xref>]. Crystal structures of the canonical and variant structures of C2A show conservation of structure, even where the sequence is not conserved. Biophysical characterisation of the interactions with phospholipids and calcium indicate that the C2A and C2Av1 domains are highly conformationally flexible [<xref ref-type="bibr" rid="B14">14</xref>]. The Fer domains (FerA, FerB, and FerI) are short conserved regions found only in the ferlin protein family and are not yet shown to be folded domains.</p>
      <fig id="F1" position="float">
        <label>Figure 1</label>
        <caption>
          <p><bold>Domain organisation of dysferlin and alignment of DysF domains. a)</bold>âMultiple domain architecture of human dyferlin protein (Gene3D and pFam). <bold>b)</bold>âMultiple sequence alignment of inner and outer DysF domain of Human Myoferlin, Dysferlin, Fer1l5; human Tecpr1 DysF domains; inner and outer DysF domain of <italic>C. elegans</italic>âFerI protein, and Yeast Pex30 DysF domain (aligned with mafft and drawn with ESPript).</p>
        </caption>
        <graphic xlink:href="1472-6807-14-3-1"/>
      </fig>
      <p>Dysferlinopathy causing mutations are dispersed throughout the length of the protein, but many fall in the DysF domains [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. One DysF domain is inserted into the other DysF domain, by gene duplication, forming an inner DysF domain and a two part (N terminal and C terminal) outer DysF domain [<xref ref-type="bibr" rid="B17">17</xref>]. The function of the DysF domain is unknown. The human myoferlin (dysferlin paralogue) inner DysF domain structure was solved by Nuclear Magenetic Resonance (NMR) and showed a novel fold. This consists of two long beta strands connected by a long loop that caps the sheet edges in certain sections [<xref ref-type="bibr" rid="B18">18</xref>]. The structure contains arginine/tryptophan stacks that holds the fold together and are largely conserved throughout DysF domain sequences (FigureÂ <xref ref-type="fig" rid="F1">1</xref>b).</p>
      <p>In this study, we have determined the three dimensional structure of human dysferlin inner DysF domain by X-ray crystallography at 1.9Â Ã. This is the first DysF domain crystal structure.</p>
    </sec>
    <sec>
      <title>Results and discussion</title>
      <sec>
        <title>Structure characterisation</title>
        <p>The structure was solved by molecular replacement with the NMR structure of the inner DysF of myoferlin [<xref ref-type="bibr" rid="B18">18</xref>]. The sequence identity between the inner DysF domain in dysferlin and myoferlin is 61% (FigureÂ <xref ref-type="fig" rid="F1">1</xref>b). Most datasets that were collected, processed and refined in space group P2<sub>1</sub>3 (cubic), with the best resolution dataset diffracting to 1.9Â Ã. A single dataset was collected in a different space group P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> (orthorhombic) to 2.2Â Ã. The crystal packing is almost the same in the two forms, but the distortions of the perfect cube in the orthorhombic structure means the monomers of the crystallographic trimer in the cubic crystals are no longer identical (FigureÂ <xref ref-type="fig" rid="F2">2</xref>a, b). This leads to some of the flexible regions (eg residues 965-671) being more visible in some chains with the orthorhombic data. Except where stated otherwise the analysis is based on the single chain in the 1.9Â Ã structure. Statistics for both datasets are summarised in TableÂ <xref ref-type="table" rid="T1">1</xref> and have been deposited in the Protein Data Bank [PDB:4CAH][PDB;4CAI].</p>
        <fig id="F2" position="float">
          <label>Figure 2</label>
          <caption>
            <p><bold>Comparison of DysF domain structures.</bold>âRibbon presentation of <bold>a)</bold>âP2<sub>1</sub>3 asymmetric unit (the beta strands are coloured in yellow, 3 turn in pink, 4 turn in tan and no structure in grey) and <bold>b)</bold>âP2<sub>1</sub>2<sub>1</sub>2<sub>1</sub>âasymmetric unit coloured by chain. <bold>c)</bold>âSuperimposed models of myoferlin NMR DysF domain (blue) with dysferlin crystal DysF domain (red). <bold>d)</bold>âTwo areas of very high B factor in dysferlin DysD domain coloured in blue (965-971) and red (1018-1021). Orientation as in FigureÂ <xref ref-type="fig" rid="F2">2</xref>a). Figure drawn with CCP4mg [<xref ref-type="bibr" rid="B19">19</xref>].</p>
          </caption>
          <graphic xlink:href="1472-6807-14-3-2"/>
        </fig>
        <table-wrap position="float" id="T1">
          <label>Table 1</label>
          <caption>
            <p>Data collection and refinement statistics of the dysferlin inner DysF domain</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left">
                  <bold>
<italic>Data collection</italic>
</bold>
                </th>
                <th align="left">
                  <bold>PDB 4CAI</bold>
                </th>
                <th align="left">
                  <bold>PDB 4CAH</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">Wavelength (Ã)<hr/></td>
                <td align="left" valign="bottom">1.037530<hr/></td>
                <td align="left" valign="bottom">0.97718<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Space group<hr/></td>
                <td align="left" valign="bottom">P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub><hr/></td>
                <td align="left" valign="bottom">P2<sub>1</sub>3<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Unit-cell parameters<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">ââa, b, c (Ã)<hr/></td>
                <td align="left" valign="bottom">74.5, 77.47, 79.89<hr/></td>
                <td align="left" valign="bottom">75.95, 75.95, 75.95<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">ââÎ±, Î², Î³ (<sup>o</sup>)<hr/></td>
                <td align="left" valign="bottom">90, 90, 90<hr/></td>
                <td align="left" valign="bottom">90, 90, 90<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Resolution range (Ã)<hr/></td>
                <td align="left" valign="bottom">50-2.2 (2.27-2.20)<hr/></td>
                <td align="left" valign="bottom">53.7-1.9 (1.94-1.9)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Total number of observation<hr/></td>
                <td align="left" valign="bottom">78153 (6922)<hr/></td>
                <td align="left" valign="bottom">115092 (7574)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Total number unique<hr/></td>
                <td align="left" valign="bottom">24062 (2084)<hr/></td>
                <td align="left" valign="bottom">11803 (760)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Completeness<hr/></td>
                <td align="left" valign="bottom">99.8 (99.9)<hr/></td>
                <td align="left" valign="bottom">100.0 (100.0)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Multiplicity<hr/></td>
                <td align="left" valign="bottom">3.2 (3.3)<hr/></td>
                <td align="left" valign="bottom">9.8 (10)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">&lt;<italic>I/Ï(I)&gt;</italic><hr/></td>
                <td align="left" valign="bottom">12.4 (2.3)<hr/></td>
                <td align="left" valign="bottom">30.5 (3.5)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">CC(1/2)<hr/></td>
                <td align="left" valign="bottom">0.976 (0.758)<hr/></td>
                <td align="left" valign="bottom">1.00 (0.847)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">R<sub>merge</sub><hr/></td>
                <td align="left" valign="bottom">0.045 (0.466)<hr/></td>
                <td align="left" valign="bottom">0.044 (0.667)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Solvent content (%)<hr/></td>
                <td align="left" valign="bottom">56.8<hr/></td>
                <td align="left" valign="bottom">53.0<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Molecule per ASU<hr/></td>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="left" valign="bottom">1<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Wilson B factor (Ã<sup>2</sup>)<hr/></td>
                <td align="left" valign="bottom">42.2<hr/></td>
                <td align="left" valign="bottom">31.05<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">
                  <italic>Refinement</italic>
                  <hr/>
                </td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Resolution range (Ã)<hr/></td>
                <td align="left" valign="bottom">44.57-2.2<hr/></td>
                <td align="left" valign="bottom">53.7-1.9<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">R<sub>work</sub><hr/></td>
                <td align="left" valign="bottom">0.1858 (0.2457)<hr/></td>
                <td align="left" valign="bottom">0.1775 (0.1932)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">R<sub>free</sub><hr/></td>
                <td align="left" valign="bottom">0.2271 (0.3102)<hr/></td>
                <td align="left" valign="bottom">0.1908 (0.2283)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Reflection, working<hr/></td>
                <td align="left" valign="bottom">22764<hr/></td>
                <td align="left" valign="bottom">11220<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Reflection, free<hr/></td>
                <td align="left" valign="bottom">1206<hr/></td>
                <td align="left" valign="bottom">549<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Average B factor<hr/></td>
                <td align="left" valign="bottom">61.0<hr/></td>
                <td align="left" valign="bottom">42.0<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Rmsd bond angle<hr/></td>
                <td align="left" valign="bottom">1.358<hr/></td>
                <td align="left" valign="bottom">1.76<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Rmsd bond length (Ã)<hr/></td>
                <td align="left" valign="bottom">0.011<hr/></td>
                <td align="left" valign="bottom">0.015<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">
                  <italic>Ramachandran Analysis</italic>
                  <hr/>
                </td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Preferred region (%)<hr/></td>
                <td align="left" valign="bottom">96.7<hr/></td>
                <td align="left" valign="bottom">95.2<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Allowed region (%)<hr/></td>
                <td align="left" valign="bottom">2.4<hr/></td>
                <td align="left" valign="bottom">2.9<hr/></td>
              </tr>
              <tr>
                <td align="left">Outliers (%)</td>
                <td align="left">0.9</td>
                <td align="left">1.9</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>Values in parentheses refer to the highest resolution shell.</p>
            <p>R<sub>merge</sub>â=âÎ£ (I -â&lt;âI&gt;) / Î£â&lt;âIâ&gt;â.</p>
            <p><italic>R</italic><sub>work</sub>â=âÎ£ (|<italic>F</italic><sub>obs</sub> |- |<italic>F</italic><sub>calc</sub>|)/ Î£|<italic>F</italic><sub>obs</sub>| for 95% of data. Rfree is the same equation for 5% of the data excluded from refinement.</p>
          </table-wrap-foot>
        </table-wrap>
        <p>The inner DysF domain construct starts at residue Met942 and ends at Gln1052 and has a Ser on the N terminus from the TEV protease site. The additional Ser, Met942 and Gln1052 are not visible in the structures. The main secondary structure consists of two long antiparallel Î²-strands, one at each terminus (N terminus 946-958, C terminus 1036-1049). These Î²-strands are connected with a long loop (77 residues). The loop caps the edge of the N terminal Î²-strand with main chain hydrogen bonds from residues 966, 971 and 973. The C terminal Î²-strand is capped with main chain hydrogen bonds from residues 993, 995, 996, 1000, 1013 and 1015. These give short Î² strands within the linking loop. There is also a single turn of 3<sub>10</sub> helix from 983 to 986 (FiguresÂ <xref ref-type="fig" rid="F1">1</xref>b, <xref ref-type="fig" rid="F2">2</xref>a). This secondary structure is also conserved in the NMR structure of the myoferlin inner DsyF domain [<xref ref-type="bibr" rid="B18">18</xref>].</p>
        <p>The structure is highly conserved between independent copies in the crystals. The crystallographic trimer of the P2<sub>1</sub>3 crystal superimposes onto the trimer in the P2<sub>1</sub>2<sub>1</sub>2<sub>1</sub> asymmetric unit with an RMSD Calpha of 0.89Â Ã over 326 residues of the trimer. The four individual chains from the two assymetric units superimpose no worse than 0.79Â Ã Calpha RMSD over 108 residues for any pair. The conservation with the NMR structure of myoferlin is also extremely high with a Calpha RMSD of 1.78Â Ã over 106 residues being the worst and 1.45Â Ã over 103 residues being the best of the 20 models (FigureÂ <xref ref-type="fig" rid="F2">2</xref>c). The biggest variation between dysferlin models is between 965 and 971 and 1018 and 1021 (FigureÂ <xref ref-type="fig" rid="F2">2</xref>d). These are also the regions with the highest temperature (B) factors in dysferlin, the regions with the largest RMS between NMR models in myoferlin, as can be seen from the CING database [<xref ref-type="bibr" rid="B20">20</xref>,<xref ref-type="bibr" rid="B21">21</xref>], and the regions that differ most between dysferlin and myoferlin. However the region from 958-960 also has high B factors, while conserving the backbone trace between structures quite well.</p>
        <p>The trimer (with 9 phosphates) is predicted to be the stable assembly by PDBePISA [<xref ref-type="bibr" rid="B22">22</xref>]. Formation of the assembly buries a total 5250Â Ã<sup>2</sup>. The interface between the protein chains (repeated 3 times in the trimer) forms 5(pisa) - 7(ccp4mg) hydrogen bonds and 3 salt bridges. Three of these are mainchain-mainchain, with Î²3 forming intermolecular Î² strand links to Î²1 as well as the intramolecular H bonds to Î²6. 2Â H bonds are mainchain-sidechain and the others are sidechain-sidechain. Indeed the formation of Î²3 is probably driven by the trimerisation. The relatively low B factor in this side of the loop may be partially caused by this packing. We have no evidence from gel filtration or NMR spectroscopy (data not shown) for the existence of a trimer, nor is there any likely way to invoke a trimer <italic>in vivo</italic>. There are two DysF domains in dysferlin and the reported oligomeric state of the full length protein is a dimer. Therefore two or four DysF domains seems more likely higher order assemblies, although extending the beta sheet either with other DysF domains or other proteins does seem to be a likely method of interaction.</p>
      </sec>
      <sec>
        <title>Arginine/tryptophan (R/W) stacks</title>
        <p>As reported for the myoferlin inner DysF domain [<xref ref-type="bibr" rid="B18">18</xref>], the dysferlin DysF domain is held together by arginine/aromatic sidechain stacking. Superficially there is a stack of arginines and tryptophans which runs the entire length of one face of the beta sheet, and a single small group on the other face (FigureÂ <xref ref-type="fig" rid="F3">3</xref>a). However, at the good resolution of these crystal structures, we can give a much confident description of the exact nature of the interactions. In particular arginines can interact with aromatics either in a stacked (ie with the guanadinium parallel to the aromatic ring- above the six membered ring) [<xref ref-type="bibr" rid="B23">23</xref>] or in an H bond (with the amino group pointing at the ring and the guanadinium plane perpendicular to the aromatic ring). Theoretical calculations favour the H bond arrangement in vacuum but the stacked arrangement in water [<xref ref-type="bibr" rid="B24">24</xref>]. We do see both these types of interaction but a number of the arginine-guanadinium groups do not lie above the centre of aromatic ring. In fact the atlas of sidechain interactions [<xref ref-type="bibr" rid="B25">25</xref>,<xref ref-type="bibr" rid="B26">26</xref>], does not have the Arg âTrp pairs above the centre of the ring in most of the clusters. Only one cluster lies above the 6 membered ring. In four of the six cases the guanadiniums lie above or beyond the NE-CZ containing edge of the ring and in one case beyond the opposite edge of the indole. In these cases there is still a hydrophobic interaction of the aliphatic sidechain with the ring and the guanadinium is available to form other H-bonds. A working definition of aliphatic stacking is that at least two side chain atoms are within 3.8Â Ã of Trp ring atoms (the CH2-CHar Van der Waals radii add up to 3.74Â Ã [<xref ref-type="bibr" rid="B27">27</xref>]).</p>
        <fig id="F3" position="float">
          <label>Figure 3</label>
          <caption>
            <p><bold>The aromatic/arginine stack motif. a)</bold>âStick representation of the residues involved in W/R stacks; arginines and lysines are coloured blue, aromatic residues are coloured green, and one cysteine residue in brown. Three forms of stack formation: <bold>b)</bold>âparallel (W1012/R1038/W965), <bold>c)</bold>âperpendicular (R1046/W992), and <bold>d)</bold>âaliphatic stacking (R1040/W1012). Maps are 2mFo-DFc from Phenix.refine contoured at 1.03 Sigma. Figure drawn with CCP4mg [<xref ref-type="bibr" rid="B19">19</xref>].</p>
          </caption>
          <graphic xlink:href="1472-6807-14-3-3"/>
        </fig>
        <p>The details of the R/W interactions are laid out in TableÂ <xref ref-type="table" rid="T2">2</xref> and examples shown in FigureÂ <xref ref-type="fig" rid="F3">3</xref>. The analysis shows that in fact there is not one continuous stack, but three on one face of the sheet. R1046 is to one side of W994, with only one non-H atom within 3.8Â Ã. Instead Cys988 forms an aromatic H bond interaction with W994. The second break occurs between, R1040 and W1042, where both side chains hydrogen bond to E955, but there is no direct interaction between the two. On the other face R1039 stacks with both F954 and W1027. Most but not all the stacking interactions are conserved in the myoferlin inner domain, but the NMR structure does not define which mode of packing is taking place. By sequence homology most of these interactions would be found in the dysferlin outer dysf domain (sequence identity 32%). The inner dysf domain of myoferlin lacks equivalents of K983 and W1042, although the overall fold is well conserved; conversely the outer dysferlin dysF domain lacks an equivalent of C988 and R1048, so in both cases the stacks will be a bit shorter.</p>
        <table-wrap position="float" id="T2">
          <label>Table 2</label>
          <caption>
            <p>Aromatic arginine stack interactions in DysF domains</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
              <col align="left"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="left">
                  <bold>Stack</bold>
                </th>
                <th align="left">
                  <bold>Dysferlin inner domain</bold>
                </th>
                <th align="left">
                  <bold>W/R type</bold>
                </th>
                <th align="left">
                  <bold>Interactions</bold>
                </th>
                <th align="left">
                  <bold>Myoferlin inner domain equivalent (Residue mentioned in interaction)</bold>
                </th>
                <th align="left">
                  <bold>Outer Dysferlin DysF equivalent</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="left" valign="bottom">1<hr/></td>
                <td align="left" valign="bottom">R1048<hr/></td>
                <td align="left" valign="bottom">Aliphatic W992<hr/></td>
                <td align="left" valign="bottom">Planar interaction to Y1034 in crystal contact<hr/></td>
                <td align="left" valign="bottom">K1029<hr/></td>
                <td align="left" valign="bottom">P1100<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H Bond to Q1010 in crystal contact<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Interacts with crystallisation phosphate<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Guanadinium Beyond NH/CZ of W992<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">1<hr/></td>
                <td align="left" valign="bottom">W992<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bonds to crystallisation phosphate<hr/></td>
                <td align="left" valign="bottom">W973<hr/></td>
                <td align="left" valign="bottom">W924<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">1<hr/></td>
                <td align="left" valign="bottom">R1046<hr/></td>
                <td align="left" valign="bottom">Perpendicular W992<hr/></td>
                <td align="left" valign="bottom">NH points to 6 membered ring of W992<hr/></td>
                <td align="left" valign="bottom">R1027<hr/></td>
                <td align="left" valign="bottom">R1096<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bonds to crystallisation phosphate<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bond to E951<hr/></td>
                <td align="left" valign="bottom">(D392)<hr/></td>
                <td align="left" valign="bottom">(A879) ?E880<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">2<hr/></td>
                <td align="left" valign="bottom">C988<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bond to 5 membered ring of W994<hr/></td>
                <td align="left" valign="bottom">C969<hr/></td>
                <td align="left" valign="bottom">P920<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">W994<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">W975<hr/></td>
                <td align="left" valign="bottom">W926<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">R1044<hr/></td>
                <td align="left" valign="bottom">Planar W994/ Aliphatic W999<hr/></td>
                <td align="left" valign="bottom">Planar stack above 5 membered ring W994<hr/></td>
                <td align="left" valign="bottom">R1025<hr/></td>
                <td align="left" valign="bottom">R1096<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">2<hr/></td>
                <td align="left" valign="bottom">W999<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">R1044 guanadinium is beyond NE/CZ edge<hr/></td>
                <td align="left" valign="bottom">W980<hr/></td>
                <td align="left" valign="bottom">W930<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Aliphatic interaction with side chain of K983<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">2<hr/></td>
                <td align="left" valign="bottom">K983<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Just over 4Â Ã above 6 membered ring of W1042<hr/></td>
                <td align="left" valign="bottom">P964<hr/></td>
                <td align="left" valign="bottom">K915<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">2<hr/></td>
                <td align="left" valign="bottom">W1042<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bond to E955<hr/></td>
                <td align="left" valign="bottom">L1023 (Q936)<hr/></td>
                <td align="left" valign="bottom">W1094 (E883)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="left" valign="bottom">R1040<hr/></td>
                <td align="left" valign="bottom">Aliphatic W1012<hr/></td>
                <td align="left" valign="bottom">H bond to E955<hr/></td>
                <td align="left" valign="bottom">R1021 (Q396)<hr/></td>
                <td align="left" valign="bottom">R1092 (E883)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Guanadinium Beyond NE-CZ of W1012<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="left" valign="bottom">W1012<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">W993<hr/></td>
                <td align="left" valign="bottom">W1069<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="left" valign="bottom">R1038<hr/></td>
                <td align="left" valign="bottom">Planar W1012<hr/></td>
                <td align="left" valign="bottom">Planar stack to 5 membered ring of W1012<hr/></td>
                <td align="left" valign="bottom">R1019<hr/></td>
                <td align="left" valign="bottom">R1090<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Planar W965<hr/></td>
                <td align="left" valign="bottom">Planar stack to 5 membered ring of W965<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="left" valign="bottom">W965<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bond to major conformation of E1031<hr/></td>
                <td align="left" valign="bottom">W946 (E1012)<hr/></td>
                <td align="left" valign="bottom">W894<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">3<hr/></td>
                <td align="left" valign="bottom">R959<hr/></td>
                <td align="left" valign="bottom">Aliphatic W965<hr/></td>
                <td align="left" valign="bottom">Guanadinum Beyond NE-CZ of W965<hr/></td>
                <td align="left" valign="bottom">R940<hr/></td>
                <td align="left" valign="bottom">K887<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">H bonds to major and minor conformations of E1031<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Opposite Face<hr/></td>
                <td align="left" valign="bottom">F954<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Y935<hr/></td>
                <td align="left" valign="bottom">Y882<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">R1039<hr/></td>
                <td align="left" valign="bottom">Planar F954<hr/></td>
                <td align="left" valign="bottom">Close to planar Stack above F954<hr/></td>
                <td align="left" valign="bottom">R1020<hr/></td>
                <td align="left" valign="bottom">R1090<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Planar W1027<hr/></td>
                <td align="left" valign="bottom">H bond to E1013<hr/></td>
                <td align="left" valign="bottom">(E994)<hr/></td>
                <td align="left" valign="bottom">(E1070)<hr/></td>
              </tr>
              <tr>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Planar Stack above 5 membered ring of W1027 closer to NE than centre<hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
                <td align="left" valign="bottom">Â <hr/></td>
              </tr>
              <tr>
                <td align="left">Â </td>
                <td align="left">W1027</td>
                <td align="left">Â </td>
                <td align="left">Â </td>
                <td align="left">W1008</td>
                <td align="left">Unclear</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec>
        <title>Dysferlinopathy mutations</title>
        <p>There are 15 missense mutations in the inner dysferlin domain reported in the Leiden dysferlin mutation database [<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B16">16</xref>]. These are summarised in TableÂ <xref ref-type="table" rid="T3">3</xref> which summarises the position. FigureÂ <xref ref-type="fig" rid="F4">4</xref> shows position of all the point mutations and close up views of the three most reported mutations. The three most frequent mutations disrupt the R/W stacks and are likely to lead to a less stable or possibly unfolded domain. The unfolded domain may lead to degradation of the entire dysferlin protein. It is also notable that there are several surface residues mutated, although in this very flat domain nearly every residue contributes to the surface, which may indicate that the DysF domain is involved in protein-protein interactions.</p>
        <table-wrap position="float" id="T3">
          <label>Table 3</label>
          <caption>
            <p><bold>List of pathogenic missense mutations in the inner dysF domain taken from the Leiden database</bold>[<xref ref-type="bibr" rid="B16">16</xref>]</p>
          </caption>
          <table frame="hsides" rules="groups" border="1">
            <colgroup>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
              <col align="center"/>
            </colgroup>
            <thead valign="top">
              <tr>
                <th align="center">
                  <bold>Residue</bold>
                </th>
                <th align="center">
                  <bold>Disease</bold>
                </th>
                <th align="center">
                  <bold>Number of reports</bold>
                </th>
                <th align="center">
                  <bold>References</bold>
                </th>
                <th align="center">
                  <bold>Role of residue</bold>
                </th>
                <th align="center">
                  <bold>Conservation score</bold>
                </th>
              </tr>
            </thead>
            <tbody valign="top">
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg959Trp</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B &amp; MM<hr/></td>
                <td align="center" valign="bottom">25<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B28">28</xref>-<xref ref-type="bibr" rid="B34">34</xref>]<hr/></td>
                <td align="center" valign="bottom">In Stack 3<hr/></td>
                <td align="center" valign="bottom">0.522<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Met968Leu</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B<hr/></td>
                <td align="center" valign="bottom">1<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B35">35</xref>]<hr/></td>
                <td align="center" valign="bottom">In loop. Poorly defined in structure and surface exposed<hr/></td>
                <td align="center" valign="bottom">0.281<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Trp992Arg</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B &amp; MM<hr/></td>
                <td align="center" valign="bottom">2<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B36">36</xref>]<hr/></td>
                <td align="center" valign="bottom">In Stack 1<hr/></td>
                <td align="center" valign="bottom">1.000<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Trp999Cys</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B &amp; MM<hr/></td>
                <td align="center" valign="bottom">24<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B35">35</xref>-<xref ref-type="bibr" rid="B40">40</xref>]<hr/></td>
                <td align="center" valign="bottom">In Stack 2<hr/></td>
                <td align="center" valign="bottom">1.000<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Glu1009Lys</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">?<hr/></td>
                <td align="center" valign="bottom">1<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B16">16</xref>]<hr/></td>
                <td align="center" valign="bottom">Surface exposed in loop. Close to phosphate in crystal<hr/></td>
                <td align="center" valign="bottom">0.411<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Gly1011Arg</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">DACM<hr/></td>
                <td align="center" valign="bottom">1<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B32">32</xref>]<hr/></td>
                <td align="center" valign="bottom">Surface exposed in a loop<hr/></td>
                <td align="center" valign="bottom">0.773<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Tyr1014Cys</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B &amp; MM<hr/></td>
                <td align="center" valign="bottom">5<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B37">37</xref>,<xref ref-type="bibr" rid="B41">41</xref>]<hr/></td>
                <td align="center" valign="bottom">Orientates Arg1038 in Stack 3. H bond OH to guanadinium<hr/></td>
                <td align="center" valign="bottom">1.000<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg1022Gln</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B<hr/></td>
                <td align="center" valign="bottom">7<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B37">37</xref>]<hr/></td>
                <td align="center" valign="bottom">Surface exposed. Poor side chain density<hr/></td>
                <td align="center" valign="bottom">0.312<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Pro1029Leu</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">MM<hr/></td>
                <td align="center" valign="bottom">2<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B42">42</xref>]<hr/></td>
                <td align="center" valign="bottom">Surface exposed<hr/></td>
                <td align="center" valign="bottom">0.062<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg1038Gln</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">LGMD2B<hr/></td>
                <td align="center" valign="bottom">7<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B28">28</xref>,<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B43">43</xref>]<hr/></td>
                <td align="center" valign="bottom">In stack 3<hr/></td>
                <td align="center" valign="bottom">1.000<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg1039Trp</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">MM<hr/></td>
                <td align="center" valign="bottom">1<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B16">16</xref>]<hr/></td>
                <td align="center" valign="bottom">Opposite face stack<hr/></td>
                <td align="center" valign="bottom">0.923<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg1039Leu</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">MM<hr/></td>
                <td align="center" valign="bottom">1<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B44">44</xref>]<hr/></td>
                <td align="center" valign="bottom">Opposite face stack<hr/></td>
                <td align="center" valign="bottom">0.923<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg1041Cys</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">MM<hr/></td>
                <td align="center" valign="bottom">2<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B31">31</xref>]<hr/></td>
                <td align="center" valign="bottom">Surface exposed. H bond to E952<hr/></td>
                <td align="center" valign="bottom">0.617<hr/></td>
              </tr>
              <tr>
                <td align="center" valign="bottom">
                  <bold>Arg1044Ser</bold>
                  <hr/>
                </td>
                <td align="center" valign="bottom">DAMT<hr/></td>
                <td align="center" valign="bottom">2<hr/></td>
                <td align="center" valign="bottom">[<xref ref-type="bibr" rid="B44">44</xref>]<hr/></td>
                <td align="center" valign="bottom">In Stack 2<hr/></td>
                <td align="center" valign="bottom">1.000<hr/></td>
              </tr>
              <tr>
                <td align="center">
                  <bold>Arg1046His</bold>
                </td>
                <td align="center">MM</td>
                <td align="center">11</td>
                <td align="center">[<xref ref-type="bibr" rid="B42">42</xref>,<xref ref-type="bibr" rid="B45">45</xref>,<xref ref-type="bibr" rid="B46">46</xref>]</td>
                <td align="center">In Stack 1</td>
                <td align="center">0.386</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <p>LGMD2B- Limb Girdle Muscular Dystrophy 2B. MM-Myoshi Myopathy, DAMT-Distal anterior Myopathy Tibial Onset, Conversation Score was calculated using alignment in FigureÂ <xref ref-type="fig" rid="F1">1</xref> and Scorecons program [<xref ref-type="bibr" rid="B47">47</xref>].</p>
          </table-wrap-foot>
        </table-wrap>
        <fig id="F4" position="float">
          <label>Figure 4</label>
          <caption>
            <p><bold>Missense mutations mapped onto DysF domain structure. (a and c)</bold>âRibbon representation showing W/R stack rotated 180 degrees about the y axis of the page; mutated residues implicated in stack formation (red), mutated residues in the surface (blue), mutated residues stabilising the arginines involved in stack formation (yellow). Other residues of the W/R stack are in green. <bold>(b)</bold>: Interaction and environment of the most common pathogenic mutations (R959, W999 and R1046). H bonds shown as black dotted lines and stacking interactions as magenta dotted lines. Figure drawn with CCP4mg [<xref ref-type="bibr" rid="B19">19</xref>].</p>
          </caption>
          <graphic xlink:href="1472-6807-14-3-4"/>
        </fig>
      </sec>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>The structure of the inner DysF domain of dysferlin confirms the unusual fold of this domain first seen in the myoferlin homologue. The high resolution of the structure allows detailed analysis of the interactions forming the R/W stacking seen in this domain. It also provides a better model for understanding the disease causing point mutations in this domain seen in dysferlin patients. The most common mutations will disrupt the R/W stacking, making the domain more unstable or inherently unfolded, probably enhancing the degradation of the protein. Some of the dysferlin mutants map to the surface, implying that protein-protein interactions may have a role in the function of this domain.</p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <sec>
        <title>Protein preparation</title>
        <p>Human dysferlin cDNA (Jain Foundation) was used to amplify the DNA encoding for the residues 943-1052. The human dysferlin inner DysF domain was cloned into pNic28Bsa4 plasmid (supplied by Dr Opher Gileadi of the Structural Genomics Consortium), which is a modified pET28a plasmid that allows ligation independent cloning [<xref ref-type="bibr" rid="B48">48</xref>]. The vector contains an N terminal histidine tag followed by a TEV protease cleavage site. The cloned sequence was confirmed by DNA sequencing and the plasmid transformed into <italic>E. coli</italic> strains Rosetta 2 (DE3) cells. One fresh colony was inoculated into 100Â ml of Luria Broth media (LB) and the culture was grown overnight. 8 Ã 500Â ml of LB were inoculated with 1% of overnight culture and incubated at 37Â°C until the optical density reached 0.5 at a wavelength of 600Â nm. Then the cultures were induced with 0.5Â mM of IPTG and incubated at 18Â°C for 20 hours. Cells were collected by centrifuging at 4Â°C at 4000Â rpm for 20 minutes and resuspended in binding buffer (20 mMTris, pHÂ 7.5, 500Â mM NaCl, 20Â mM imidazole, 10Â mM 2-mercaptoethanol). The cells were stored at -20Â°C. After incubating with EDTA free protease inhibitor cocktail (Roche Applied Science, Switzerland), 0.1% Triton X-100 and DNAseI on ice for 30 minutes, the cells were sonicated at 20Â W output for 4 minutes of 4 second on/off pulses for three cycles on ice and then centrifuged at 48,000Â g for 1 hour. The protein lysate was applied to a HisTrap (GE Healthcare) affinity column. The column was washed with binding buffer for 10 column volumes and the protein eluted in 20Â mM Tris, pHÂ 7.5, 500Â mM NaCl, 500Â mM Imidazole, 10Â mM 2-mercaptoethanol buffer. The eluents containing the dysF domain were pooled together and treated with TEV protease for 20Â h at 4Â°C to remove the histidine tag. Then the volume was decreased to 4Â ml by Vivaspin concentrator (Sartorius, Germany) with 5,000Â Da molecular weight cutoff. The sample was further purified by size exclusion chromatography using Superdex 200 16/60 column (GE, Healthcare). The protein was purified further by anion exchange chromatography (Resource Q) on a gradient of 0-0.5Â M NaCl in 20Â mM Tris, pHÂ 7.5, and 5Â mM 2-mercaptoethanol. The protein concentration was estimated using NanoDrop spectrophotometer at UV light absorbance at 280Â nm (absorbance coefficientâ=â45950Â M<sup>-1</sup>âcm<sup>-1</sup>). The protein sample was concentrated to 10Â mg/ml (750Â Î¼M) in final buffer (20Â mM Tris-HCl, pHÂ 7.5, 120Â mM NaCl, and 5Â mM 2-mercaptoethanol) and used for crystallisation trials.</p>
      </sec>
      <sec>
        <title>Protein crystallisation and structure determination</title>
        <p>The inner DysF domain was screened for crystallisation at 16Â°C, by the sitting-drop method in 96- well crystallisation plates (Molecular Dimensions), using PACT screen [<xref ref-type="bibr" rid="B49">49</xref>]. After 11 days, small crystals appeared in a drop with mother liquor consisting of 0.2Â M NaBr and 20% PEG 3350. This crystallisation could not be reproduced initially. 0.2Â M NaBr was then added to the protein sample and the crystallisation screen was done again. Bigger crystals were produced in one day, where the reservoir contained 0.04Â M potassium dihydrogen phosphate, 16%Â w/v PEG 8000 and 20%Â v/v Glycerol. 0.3Â mm cubic crystals were grown by the hanging drop method based on this condition. The crystal was cryoprotected in crystallisation buffer with the glycerol concentration increased to 25%. Initial diffraction data was collected to 2.3Â Ã in house using MicroMax TM -007 rotating anode X-ray generator (Î»â=â1.54Â Ã) and Saturn 944+ CCD detector with Varimax optics. Further data was collected at Soleil beamline proxima 1 and at beam ID29 at ESRF. Diffraction images were processed using XDS software package [<xref ref-type="bibr" rid="B50">50</xref>], and scaled using aimless in the CCP4 program suite [<xref ref-type="bibr" rid="B51">51</xref>]. The initial phases of the dysferlin inner DysF domain were determined by molecular replacement with the program Mr Bump [<xref ref-type="bibr" rid="B52">52</xref>] using human myoferlin inner DysF domain [<xref ref-type="bibr" rid="B18">18</xref>] [PDB:2K2O] as the search model. The model was manually rebuilt in COOT [<xref ref-type="bibr" rid="B53">53</xref>] and refined initially in Refmac [<xref ref-type="bibr" rid="B54">54</xref>] and then continued in PHENIX [<xref ref-type="bibr" rid="B55">55</xref>]. Data collection and refinement statistics are summarized in TableÂ <xref ref-type="table" rid="T1">1</xref>.</p>
        <p>No human subjects were directly used in this study. Human mutation data was taken from publicly accessible databases.</p>
      </sec>
    </sec>
    <sec>
      <title>Abbreviations</title>
      <p>Ã: Ãngstrom (10<sup>-10</sup>Â m); CING: Common Interface for NMR structure Generation; EDTA: Ethylenediaminetetraacetic acid; IPTG: Isopropyl Î²-D-1-thiogalactopyranoside; LB: Luria broth; NMR: Nuclear magnetic resonance; RMSD: Root mean square deviation; R/W: Arginine/Tryptophan stacks; TEV: Tobacco etch virus.</p>
    </sec>
    <sec>
      <title>Competing interests</title>
      <p>The authors declare that they have no competing interest.</p>
    </sec>
    <sec>
      <title>Authorsâ contributions</title>
      <p>AS prepared the expression construct and protein, grew the crystals and carried out the refinement and drew most of the figures. AC collected the diffraction data and advised on crystallisation. CY and CO defined the domain boundaries and the multiple domain architecture. NK wrote the first draft of the manuscript. CO and NK devised the project and trained AS. All authors have read and agreed the final manuscript.</p>
    </sec>
  </body>
  <back>
    <sec>
      <title>Acknowledgements</title>
      <p>AS is supported by a Biotechnology and Biological Research Council (BBSRC) studentship BB/F016948/1. We thank the Jain Foundation for the gift of human dysferlin cDNA and Dr Opher Gileadi of the Structural Genomics Consortium for the gift of pNic28Bsa4.</p>
    </sec>
    <ref-list>
      <ref id="B1">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bashir</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Britton</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Strachan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Keers</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vafiadaki</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lako</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Richard</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Marchand</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bourg</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Argov</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
          <article-title>A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B</article-title>
          <source>Nat Genet</source>
          <year>1998</year>
          <volume>20</volume>
          <fpage>37</fpage>
          <lpage>42</lpage>
          <pub-id pub-id-type="doi">10.1038/1689</pub-id>
          <?supplied-pmid 9731527?>
          <pub-id pub-id-type="pmid">9731527</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B2">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Aoki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Illa</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Fardeau</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Angelini</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Serrano</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Urtizberea</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Hentati</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Hamida</surname>
            <given-names>MB</given-names>
          </name>
          <etal/>
          <article-title>Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy</article-title>
          <source>Nat Genet</source>
          <year>1998</year>
          <volume>20</volume>
          <fpage>31</fpage>
          <lpage>36</lpage>
          <pub-id pub-id-type="doi">10.1038/1682</pub-id>
          <?supplied-pmid 9731526?>
          <pub-id pub-id-type="pmid">9731526</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B3">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Illa</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Serrano-Munuera</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gallardo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Lasa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Rojas-GarcÃ­a</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Palmer</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gallano</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Baiget</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Matsuda</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>RH</given-names>
          </name>
          <article-title>Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype</article-title>
          <source>Ann Neurol</source>
          <year>2001</year>
          <volume>49</volume>
          <fpage>130</fpage>
          <lpage>134</lpage>
          <pub-id pub-id-type="doi">10.1002/1531-8249(200101)49:1&lt;130::AID-ANA22&gt;3.0.CO;2-0</pub-id>
          <?supplied-pmid 11198284?>
          <pub-id pub-id-type="pmid">11198284</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B4">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bansal</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Miyake</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Vogel</surname>
            <given-names>SS</given-names>
          </name>
          <name>
            <surname>Groh</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>CC</given-names>
          </name>
          <name>
            <surname>Williamson</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>McNeil</surname>
            <given-names>PL</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>KP</given-names>
          </name>
          <article-title>Defective membrane repair in dysferlin-deficient muscular dystrophy</article-title>
          <source>Nature</source>
          <year>2003</year>
          <volume>423</volume>
          <fpage>168</fpage>
          <lpage>172</lpage>
          <pub-id pub-id-type="doi">10.1038/nature01573</pub-id>
          <?supplied-pmid 12736685?>
          <pub-id pub-id-type="pmid">12736685</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B5">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Bansal</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Campbell</surname>
            <given-names>KP</given-names>
          </name>
          <article-title>Dysferlin and the plasma membrane repair in muscular dystrophy</article-title>
          <source>Trends Cell Biol</source>
          <year>2004</year>
          <volume>14</volume>
          <fpage>206</fpage>
          <lpage>213</lpage>
          <pub-id pub-id-type="doi">10.1016/j.tcb.2004.03.001</pub-id>
          <?supplied-pmid 15066638?>
          <pub-id pub-id-type="pmid">15066638</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B6">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Evesson</surname>
            <given-names>FJ</given-names>
          </name>
          <name>
            <surname>Sutton</surname>
            <given-names>RB</given-names>
          </name>
          <name>
            <surname>North</surname>
            <given-names>KN</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>ST</given-names>
          </name>
          <article-title>Ferlins: regulators of vesicle fusion for auditory neurotransmission, receptor trafficking and membrane repair</article-title>
          <source>Traffic</source>
          <year>2012</year>
          <volume>13</volume>
          <fpage>185</fpage>
          <lpage>194</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1600-0854.2011.01267.x</pub-id>
          <?supplied-pmid 21838746?>
          <pub-id pub-id-type="pmid">21838746</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B7">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Lek</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lek</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>North</surname>
            <given-names>KN</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>ST</given-names>
          </name>
          <article-title>Phylogenetic analysis of ferlin genes reveals ancient eukaryotic origins</article-title>
          <source>BMC Evolutionary Biology</source>
          <year>2010</year>
          <volume>10</volume>
          <fpage>231</fpage>
          <pub-id pub-id-type="doi">10.1186/1471-2148-10-231</pub-id>
          <?supplied-pmid 20667140?>
          <pub-id pub-id-type="pmid">20667140</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B8">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cuff</surname>
            <given-names>AL</given-names>
          </name>
          <name>
            <surname>Sillitoe</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Clegg</surname>
            <given-names>AB</given-names>
          </name>
          <name>
            <surname>Rentzsch</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Furnham</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pellegrini-Calace</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jones</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Orengo</surname>
            <given-names>CA</given-names>
          </name>
          <article-title>Extending CATH: increasing coverage of the protein structure universe and linking structure with function</article-title>
          <source>Nucleic Acids Res</source>
          <year>2011</year>
          <volume>39</volume>
          <fpage>D420</fpage>
          <lpage>D426</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkq1001</pub-id>
          <?supplied-pmid 21097779?>
          <pub-id pub-id-type="pmid">21097779</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B9">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Letunic</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Doerks</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
          <article-title>SMART 7: recent updates to the protein domain annotation resource</article-title>
          <source>Nucleic Acids Res</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>D302</fpage>
          <lpage>D305</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkr931</pub-id>
          <?supplied-pmid 22053084?>
          <pub-id pub-id-type="pmid">22053084</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B10">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Punta</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Coggill</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Eberhardt</surname>
            <given-names>RY</given-names>
          </name>
          <name>
            <surname>Mistry</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Tate</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Boursnell</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Forslund</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ceric</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Clements</surname>
            <given-names>J</given-names>
          </name>
          <etal/>
          <article-title>The Pfam protein families database</article-title>
          <source>Nucleic Acids Res</source>
          <year>2012</year>
          <volume>40</volume>
          <fpage>D290</fpage>
          <lpage>D301</lpage>
          <pub-id pub-id-type="doi">10.1093/nar/gkr1065</pub-id>
          <?supplied-pmid 22127870?>
          <pub-id pub-id-type="pmid">22127870</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B11">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Davis</surname>
            <given-names>DB</given-names>
          </name>
          <name>
            <surname>Doherty</surname>
            <given-names>KR</given-names>
          </name>
          <name>
            <surname>Delmonte</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>McNally</surname>
            <given-names>EM</given-names>
          </name>
          <article-title>Calcium-sensitive phospholipid binding properties of normal and mutant ferlin C2 domains</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>22883</fpage>
          <lpage>22888</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M201858200</pub-id>
          <?supplied-pmid 11959863?>
          <pub-id pub-id-type="pmid">11959863</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B12">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Therrien</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Di Fulvio</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pickles</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sinnreich</surname>
            <given-names>M</given-names>
          </name>
          <article-title>Characterization of lipid binding specificities of dysferlin C2 domains reveals vovel interactions with phosphoinositides</article-title>
          <source>Biochemistry</source>
          <year>2009</year>
          <volume>48</volume>
          <fpage>2377</fpage>
          <lpage>2384</lpage>
          <pub-id pub-id-type="doi">10.1021/bi802242r</pub-id>
          <?supplied-pmid 19253956?>
          <pub-id pub-id-type="pmid">19253956</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B13">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Pallikkuth</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Mignery</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Robia</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>R</given-names>
          </name>
          <article-title>Dysferlin forms a dimer mediated by the C2 domains and the transmembrane domain in vitro and in living cells</article-title>
          <source>PloS one</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>e27884</fpage>
          <lpage>e27884</lpage>
          <pub-id pub-id-type="doi">10.1371/journal.pone.0027884</pub-id>
          <?supplied-pmid 22110769?>
          <pub-id pub-id-type="pmid">22110769</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B14">
        <mixed-citation publication-type="other">
          <name>
            <surname>Fuson</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rice</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mahling</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Snow</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nayak</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Shanbhogue</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Meyer Austin</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Redpath</surname>
            <given-names>GMI</given-names>
          </name>
          <name>
            <surname>Hinderliter</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>ST</given-names>
          </name>
          <name>
            <surname>Sutton</surname>
            <given-names>RB</given-names>
          </name>
          <article-title>Alternate Splicing of Dysferlin C2A Confers Ca2+-Dependent and Ca2+-Independent Binding for Membrane Repair</article-title>
          <source>Structure</source>
          <year>2014</year>
          <comment>In press</comment>
        </mixed-citation>
      </ref>
      <ref id="B15">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aartsma-Rus</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Van Deutekom</surname>
            <given-names>JCT</given-names>
          </name>
          <name>
            <surname>Fokkema</surname>
            <given-names>IF</given-names>
          </name>
          <name>
            <surname>Van Ommen</surname>
            <given-names>GJB</given-names>
          </name>
          <name>
            <surname>Den Dunnen</surname>
            <given-names>JT</given-names>
          </name>
          <article-title>Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule</article-title>
          <source>Muscle Nerve</source>
          <year>2006</year>
          <volume>34</volume>
          <fpage>135</fpage>
          <lpage>144</lpage>
          <pub-id pub-id-type="doi">10.1002/mus.20586</pub-id>
          <?supplied-pmid 16770791?>
          <pub-id pub-id-type="pmid">16770791</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B16">
        <mixed-citation publication-type="other">
          <article-title>
            <bold>Leiden muscular dystrophy database dysferlin sequence variants</bold>
          </article-title>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.dmd.nl/dysf_seqvar.html">http://www.dmd.nl/dysf_seqvar.html</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B17">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ponting</surname>
            <given-names>CP</given-names>
          </name>
          <name>
            <surname>Mott</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bork</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Copley</surname>
            <given-names>RR</given-names>
          </name>
          <article-title>Novel protein domains and repeats in Drosophila melanogaster: insights into structure, function, and evolution</article-title>
          <source>Genome Res</source>
          <year>2001</year>
          <volume>11</volume>
          <fpage>1996</fpage>
          <lpage>2008</lpage>
          <pub-id pub-id-type="doi">10.1101/gr.198701</pub-id>
          <?supplied-pmid 11731489?>
          <pub-id pub-id-type="pmid">11731489</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B18">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Patel</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Harris</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Geddes</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Strehle</surname>
            <given-names>EM</given-names>
          </name>
          <name>
            <surname>Watson</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Bashir</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Bushby</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Driscoll</surname>
            <given-names>PC</given-names>
          </name>
          <name>
            <surname>Keep</surname>
            <given-names>NH</given-names>
          </name>
          <article-title>Solution structure of the inner DysF domain of myoferlin and implications for limb girdle muscular dystrophy type 2b</article-title>
          <source>J Mol Biol</source>
          <year>2008</year>
          <volume>379</volume>
          <fpage>981</fpage>
          <lpage>990</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2008.04.046</pub-id>
          <?supplied-pmid 18495154?>
          <pub-id pub-id-type="pmid">18495154</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B19">
        <mixed-citation publication-type="journal">
          <name>
            <surname>McNicholas</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Potterton</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Wilson</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Noble</surname>
            <given-names>MEM</given-names>
          </name>
          <article-title>Presenting your structures: the CCP4mg molecular-graphics software</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2011</year>
          <volume>67</volume>
          <fpage>386</fpage>
          <lpage>394</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444911007281</pub-id>
          <?supplied-pmid 21460457?>
          <pub-id pub-id-type="pmid">21460457</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B20">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Doreleijers</surname>
            <given-names>JF</given-names>
          </name>
          <name>
            <surname>da Silva</surname>
            <given-names>AWS</given-names>
          </name>
          <name>
            <surname>Krieger</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nabuurs</surname>
            <given-names>SB</given-names>
          </name>
          <name>
            <surname>Spronk</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Stevens</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Vranken</surname>
            <given-names>WF</given-names>
          </name>
          <name>
            <surname>Vriend</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Vuister</surname>
            <given-names>GW</given-names>
          </name>
          <article-title>CING: an integrated residue-based structure validation program suite</article-title>
          <source>Journal of Biomolecular Nmr</source>
          <year>2012</year>
          <volume>54</volume>
          <fpage>267</fpage>
          <lpage>283</lpage>
          <pub-id pub-id-type="doi">10.1007/s10858-012-9669-7</pub-id>
          <?supplied-pmid 22986687?>
          <pub-id pub-id-type="pmid">22986687</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B21">
        <mixed-citation publication-type="other">
          <article-title>
            <bold>CING database RMS Data for 2k2o</bold>
          </article-title>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://nmr.cmbi.ru.nl/NRG-CING/data/k2/2k2o/2k2o.cing/2k2o/Cing/2k2o_01_cv_rms.png">http://nmr.cmbi.ru.nl/NRG-CING/data/k2/2k2o/2k2o.cing/2k2o/Cing/2k2o_01_cv_rms.png</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B22">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Krissinel</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Henrick</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Inference of macromolecular assemblies from crystalline state</article-title>
          <source>J Mol Biol</source>
          <year>2007</year>
          <volume>372</volume>
          <fpage>774</fpage>
          <lpage>797</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jmb.2007.05.022</pub-id>
          <?supplied-pmid 17681537?>
          <pub-id pub-id-type="pmid">17681537</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B23">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Flocco</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Mowbray</surname>
            <given-names>SL</given-names>
          </name>
          <article-title>Planar stacking interactions of arginine and aromatic side-chains in proteins</article-title>
          <source>J Mol Biol</source>
          <year>1994</year>
          <volume>235</volume>
          <fpage>709</fpage>
          <lpage>717</lpage>
          <pub-id pub-id-type="doi">10.1006/jmbi.1994.1022</pub-id>
          <?supplied-pmid 8289290?>
          <pub-id pub-id-type="pmid">8289290</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B24">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Ma</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Dougherty</surname>
            <given-names>DA</given-names>
          </name>
          <article-title>The cation-pi interaction</article-title>
          <source>Chem Rev</source>
          <year>1997</year>
          <volume>97</volume>
          <fpage>1303</fpage>
          <lpage>1324</lpage>
          <pub-id pub-id-type="doi">10.1021/cr9603744</pub-id>
          <?supplied-pmid 11851453?>
          <pub-id pub-id-type="pmid">11851453</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B25">
        <mixed-citation publication-type="book">
          <name>
            <surname>Singh</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Thornton</surname>
            <given-names>JM</given-names>
          </name>
          <source>Atlas of Protein Side-Chain Interactions</source>
          <year>1992</year>
          <publisher-name>Oxford: IRL Press</publisher-name>
        </mixed-citation>
      </ref>
      <ref id="B26">
        <mixed-citation publication-type="other">
          <article-title>
            <bold>Atlas of side chain interactions</bold>
          </article-title>
          <comment>
            <ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/thornton-srv/databases/sidechains">http://www.ebi.ac.uk/thornton-srv/databases/sidechains</ext-link>
          </comment>
        </mixed-citation>
      </ref>
      <ref id="B27">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Li</surname>
            <given-names>AJ</given-names>
          </name>
          <name>
            <surname>Nussinov</surname>
            <given-names>R</given-names>
          </name>
          <article-title>A set of van der Waals and Coulombic radii of protein atoms for molecular and solvent-accessible surface calculation, packing evaluation, and docking</article-title>
          <source>Proteins-Structure Function and Genetics</source>
          <year>1998</year>
          <volume>32</volume>
          <fpage>111</fpage>
          <lpage>127</lpage>
          <pub-id pub-id-type="doi">10.1002/(SICI)1097-0134(19980701)32:1&lt;111::AID-PROT12&gt;3.0.CO;2-H</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B28">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cagliani</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Fortunato</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Giorda</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Rodolico</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Bonaglia</surname>
            <given-names>MC</given-names>
          </name>
          <name>
            <surname>Sironi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>D'Angelo</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Prelle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Locatelli</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Toscano</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Molecular analysis of LGMD-2B and MM patients: identification of novel DYSF mutations and possible founder effect in the Italian population</article-title>
          <source>Neuromuscul Disord</source>
          <year>2003</year>
          <volume>13</volume>
          <fpage>788</fpage>
          <lpage>795</lpage>
          <pub-id pub-id-type="doi">10.1016/S0960-8966(03)00133-0</pub-id>
          <?supplied-pmid 14678801?>
          <pub-id pub-id-type="pmid">14678801</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B29">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cagliani</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Magri</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Toscano</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Merlini</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Fortunato</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lamperti</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rodolico</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Prelle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sironi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aguennouz</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
          <article-title>Mutation finding in patients with dysferlin deficiency and role of the dysferlin interacting proteins annexin A1 and A2 in muscular dystrophies</article-title>
          <source>Hum Mutat</source>
          <year>2005</year>
          <volume>26</volume>
          <fpage>283</fpage>
          <pub-id pub-id-type="pmid">16100712</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B30">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Guglieri</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Magri</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>D'Angelo</surname>
            <given-names>MG</given-names>
          </name>
          <name>
            <surname>Prelle</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Morandi</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Rodolico</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Cagliani</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Mora</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Fortunato</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Bordoni</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Clinical, molecular, and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients</article-title>
          <source>Hum Mutat</source>
          <year>2008</year>
          <volume>29</volume>
          <fpage>258</fpage>
          <lpage>266</lpage>
          <pub-id pub-id-type="doi">10.1002/humu.20642</pub-id>
          <?supplied-pmid 17994539?>
          <pub-id pub-id-type="pmid">17994539</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B31">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kawabe</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nishino</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Angelini</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>YK</given-names>
          </name>
          <article-title>Dysferlin mutation analysis in a group of Italian patients with limb-girdle muscular dystrophy and Miyoshi myopathy</article-title>
          <source>Eur J Neurol</source>
          <year>2004</year>
          <volume>11</volume>
          <fpage>657</fpage>
          <lpage>661</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-1331.2004.00755.x</pub-id>
          <?supplied-pmid 15469449?>
          <pub-id pub-id-type="pmid">15469449</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B32">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Klinge</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Aboumousa</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Eagle</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Hudson</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sarkozy</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Vita</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Charlton</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Roberts</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Straub</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Barresi</surname>
            <given-names>R</given-names>
          </name>
          <etal/>
          <article-title>New aspects on patients affected by dysferlin deficient muscular dystrophy</article-title>
          <source>J Neurol Neurosurg Psychiatry</source>
          <year>2010</year>
          <volume>81</volume>
          <fpage>946</fpage>
          <lpage>953</lpage>
          <pub-id pub-id-type="doi">10.1136/jnnp.2009.178038</pub-id>
          <?supplied-pmid 19528035?>
          <pub-id pub-id-type="pmid">19528035</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B33">
        <mixed-citation publication-type="journal">
          <name>
            <surname>de Luna</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gallardo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Soriano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dominguez-Perles</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>de la Torre</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rojas-Garcia</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Garcia-Verdugo</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Illa</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Absence of dysferlin alters myogenin expression and delays human muscle differentiation "in vitro"</article-title>
          <source>J Biol Chem</source>
          <year>2006</year>
          <volume>281</volume>
          <fpage>17092</fpage>
          <lpage>17098</lpage>
          <pub-id pub-id-type="doi">10.1074/jbc.M601885200</pub-id>
          <?supplied-pmid 16608842?>
          <pub-id pub-id-type="pmid">16608842</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B34">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Fanin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nascimbeni</surname>
            <given-names>AC</given-names>
          </name>
          <name>
            <surname>Angelini</surname>
            <given-names>C</given-names>
          </name>
          <article-title>Muscle protein analysis in the detection of heterozygotes for recessive limb girdle muscular dystrophy type 2B and 2E</article-title>
          <source>Neuromuscul Disord</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>792</fpage>
          <lpage>799</lpage>
          <pub-id pub-id-type="doi">10.1016/j.nmd.2006.06.010</pub-id>
          <?supplied-pmid 16934466?>
          <pub-id pub-id-type="pmid">16934466</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B35">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kesari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fukuda</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Knoblach</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Bashir</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Nader</surname>
            <given-names>GA</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Nagaraju</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Hoffman</surname>
            <given-names>EP</given-names>
          </name>
          <article-title>Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset</article-title>
          <source>Am J Pathol</source>
          <year>2008</year>
          <volume>173</volume>
          <fpage>1476</fpage>
          <lpage>1487</lpage>
          <pub-id pub-id-type="doi">10.2353/ajpath.2008.080098</pub-id>
          <?supplied-pmid 18832576?>
          <pub-id pub-id-type="pmid">18832576</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B36">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Cho</surname>
            <given-names>HJ</given-names>
          </name>
          <name>
            <surname>Sung</surname>
            <given-names>DH</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>EJ</given-names>
          </name>
          <name>
            <surname>Yoon</surname>
            <given-names>CH</given-names>
          </name>
          <name>
            <surname>Ki</surname>
            <given-names>CS</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>JW</given-names>
          </name>
          <article-title>Clinical and genetic analysis of Korean patients with Miyoshi myopathy: identification of three novel mutations in the DYSF gene</article-title>
          <source>J Korean Med Sci</source>
          <year>2006</year>
          <volume>21</volume>
          <fpage>724</fpage>
          <lpage>727</lpage>
          <pub-id pub-id-type="doi">10.3346/jkms.2006.21.4.724</pub-id>
          <?supplied-pmid 16891820?>
          <pub-id pub-id-type="pmid">16891820</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B37">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Hattori</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Nagata</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Oya</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Aoki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Ito</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Suzuki</surname>
            <given-names>N</given-names>
          </name>
          <article-title>A novel compound heterozygous dysferlin mutation in Miyoshi myopathy siblings responding to dantrolene</article-title>
          <source>Eur J Neurol</source>
          <year>2007</year>
          <volume>14</volume>
          <fpage>1288</fpage>
          <lpage>1291</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-1331.2007.01958.x</pub-id>
          <?supplied-pmid 17868276?>
          <pub-id pub-id-type="pmid">17868276</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B38">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Tagawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kawabe</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Yamanaka</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Matsumura</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Goto</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nonaka</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Nishino</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>YK</given-names>
          </name>
          <article-title>Protein and gene analyses of dysferlinopathy in a large group of Japanese muscular dystrophy patients</article-title>
          <source>J Neurol Sci</source>
          <year>2003</year>
          <volume>211</volume>
          <fpage>23</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="doi">10.1016/S0022-510X(03)00041-8</pub-id>
          <?supplied-pmid 12767493?>
          <pub-id pub-id-type="pmid">12767493</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B39">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Takahashi</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Aoki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tateyama</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kondo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Mizuno</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Onodera</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Takano</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kawai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kamakura</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mochizuki</surname>
            <given-names>H</given-names>
          </name>
          <etal/>
          <article-title>Dysferlin mutations in Japanese Miyoshi myopathy: relationship to phenotype</article-title>
          <source>Neurology</source>
          <year>2003</year>
          <volume>60</volume>
          <fpage>1799</fpage>
          <lpage>1804</lpage>
          <pub-id pub-id-type="doi">10.1212/01.WNL.0000068333.43005.12</pub-id>
          <?supplied-pmid 12796534?>
          <pub-id pub-id-type="pmid">12796534</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B40">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Matsuda</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hayashi</surname>
            <given-names>YK</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Aoki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Murayama</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nishino</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Nonaka</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Arahata</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>RH</given-names>
          </name>
          <article-title>The sarcolemmal proteins dysferlin and caveolin-3 interact in skeletal muscle</article-title>
          <source>Hum Mol Genet</source>
          <year>2001</year>
          <volume>10</volume>
          <fpage>1761</fpage>
          <lpage>1766</lpage>
          <pub-id pub-id-type="doi">10.1093/hmg/10.17.1761</pub-id>
          <?supplied-pmid 11532985?>
          <pub-id pub-id-type="pmid">11532985</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B41">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Rosales</surname>
            <given-names>XQ</given-names>
          </name>
          <name>
            <surname>Gastier-Foster</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Lewis</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vinod</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Thrush</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Astbury</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Pyatt</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Reshmi</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Sahenk</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Mendell</surname>
            <given-names>JR</given-names>
          </name>
          <article-title>Novel diagnostic features of dysferlinopathies</article-title>
          <source>Muscle Nerve</source>
          <year>2010</year>
          <volume>42</volume>
          <fpage>14</fpage>
          <lpage>21</lpage>
          <pub-id pub-id-type="doi">10.1002/mus.21650</pub-id>
          <?supplied-pmid 20544924?>
          <pub-id pub-id-type="pmid">20544924</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B42">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Krahn</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wein</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lostal</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Bourg-Alibert</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nguyen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Courrier</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Vial</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Labelle</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>De Petris</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Borges</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
          <article-title>Partial functionality of a mini-dysferlin molecule identified in a patient affected with moderately severe primary dysferlinopathy</article-title>
          <source>Neuromuscul Disord</source>
          <year>2008</year>
          <volume>18</volume>
          <fpage>781</fpage>
          <lpage>781</lpage>
        </mixed-citation>
      </ref>
      <ref id="B43">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nagaraju</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Rawat</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Veszelovszky</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Thapliyal</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Kesari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sparks</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Raben</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Plotz</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Hoffman</surname>
            <given-names>EP</given-names>
          </name>
          <article-title>Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B</article-title>
          <source>Am J Pathol</source>
          <year>2008</year>
          <volume>172</volume>
          <fpage>774</fpage>
          <lpage>785</lpage>
          <pub-id pub-id-type="doi">10.2353/ajpath.2008.070327</pub-id>
          <?supplied-pmid 18276788?>
          <pub-id pub-id-type="pmid">18276788</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B44">
        <mixed-citation publication-type="journal">
          <name>
            <surname>de Luna</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Gallardo</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Soriano</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Dominguez-Perles</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>de la Torre</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Rojas-Garcia</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Garcia-Verdugo</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Illa</surname>
            <given-names>I</given-names>
          </name>
          <article-title>Absence of dysferlin alters myogenin expression and delays human muscle differentiation 'in vitro'</article-title>
          <source>Neuromuscul Disord</source>
          <year>2006</year>
          <volume>16</volume>
          <fpage>S57</fpage>
          <lpage>S57</lpage>
        </mixed-citation>
      </ref>
      <ref id="B45">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Nguyen</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bassez</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Eymard</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Levy</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Pouget</surname>
            <given-names>J</given-names>
          </name>
          <article-title>Phenotypic and genetic analysis in a series of 55 patients with dysferlinopathy</article-title>
          <source>Neurology</source>
          <year>2005</year>
          <volume>64</volume>
          <fpage>A413</fpage>
          <lpage>A414</lpage>
        </mixed-citation>
      </ref>
      <ref id="B46">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Aoki</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Takahashi</surname>
            <given-names>T</given-names>
          </name>
          <article-title>Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)</article-title>
          <source>Rinsho shinkeigaku = Clinical neurology</source>
          <year>2005</year>
          <volume>45</volume>
          <fpage>938</fpage>
          <lpage>942</lpage>
          <?supplied-pmid 16447768?>
          <pub-id pub-id-type="pmid">16447768</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B47">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Valdar</surname>
            <given-names>WS</given-names>
          </name>
          <article-title>Scoring residue conservation</article-title>
          <source>Proteins</source>
          <year>2002</year>
          <volume>48</volume>
          <fpage>227</fpage>
          <lpage>241</lpage>
          <pub-id pub-id-type="doi">10.1002/prot.10146</pub-id>
          <?supplied-pmid 12112692?>
          <pub-id pub-id-type="pmid">12112692</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B48">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Savitsky</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bray</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cooper</surname>
            <given-names>CD</given-names>
          </name>
          <name>
            <surname>Marsden</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>Mahajan</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Burgess-Brown</surname>
            <given-names>NA</given-names>
          </name>
          <name>
            <surname>Gileadi</surname>
            <given-names>O</given-names>
          </name>
          <article-title>High-throughput production of human proteins for crystallization: the SGC experience</article-title>
          <source>J Struct Biol</source>
          <year>2010</year>
          <volume>172</volume>
          <fpage>3</fpage>
          <lpage>13</lpage>
          <pub-id pub-id-type="doi">10.1016/j.jsb.2010.06.008</pub-id>
          <?supplied-pmid 20541610?>
          <pub-id pub-id-type="pmid">20541610</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B49">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Newman</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Egan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Walter</surname>
            <given-names>TS</given-names>
          </name>
          <name>
            <surname>Meged</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Berry</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Ben Jelloul</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sussman</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Stuart</surname>
            <given-names>DI</given-names>
          </name>
          <name>
            <surname>Perrakis</surname>
            <given-names>A</given-names>
          </name>
          <article-title>Towards rationalization of crystallization screening for small- to medium-sized academic laboratories: the PACT/JCSG+ strategy</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2005</year>
          <volume>61</volume>
          <fpage>1426</fpage>
          <lpage>1431</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444905024984</pub-id>
          <?supplied-pmid 16204897?>
          <pub-id pub-id-type="pmid">16204897</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B50">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Kabsch</surname>
            <given-names>W</given-names>
          </name>
          <article-title>XDS</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>125</fpage>
          <lpage>132</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444909047337</pub-id>
          <?supplied-pmid 20124692?>
          <pub-id pub-id-type="pmid">20124692</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B51">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Evans</surname>
            <given-names>PR</given-names>
          </name>
          <article-title>An introduction to data reduction: space-group determination, scaling and intensity statistics</article-title>
          <source>Acta Crystallographica Section D-Biological Crystallography</source>
          <year>2011</year>
          <volume>67</volume>
          <fpage>282</fpage>
          <lpage>292</lpage>
          <pub-id pub-id-type="doi">10.1107/S090744491003982X</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B52">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Keegan</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Winn</surname>
            <given-names>MD</given-names>
          </name>
          <article-title>MrBUMP: an automated pipeline for molecular replacement</article-title>
          <source>Acta Crystallographica Section D-Biological Crystallography</source>
          <year>2008</year>
          <volume>64</volume>
          <fpage>119</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444907037195</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B53">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Emsley</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lohkamp</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Scott</surname>
            <given-names>WG</given-names>
          </name>
          <name>
            <surname>Cowtan</surname>
            <given-names>K</given-names>
          </name>
          <article-title>Features and development of Coot</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>486</fpage>
          <lpage>501</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444910007493</pub-id>
          <?supplied-pmid 20383002?>
          <pub-id pub-id-type="pmid">20383002</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B54">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Murshudov</surname>
            <given-names>GN</given-names>
          </name>
          <name>
            <surname>Vagin</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Dodson</surname>
            <given-names>EJ</given-names>
          </name>
          <article-title>Refinement of macromolecular structures by the maximum-likelihood method</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>1997</year>
          <volume>53</volume>
          <fpage>240</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444996012255</pub-id>
          <?supplied-pmid 15299926?>
          <pub-id pub-id-type="pmid">15299926</pub-id>
        </mixed-citation>
      </ref>
      <ref id="B55">
        <mixed-citation publication-type="journal">
          <name>
            <surname>Adams</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Afonine</surname>
            <given-names>PV</given-names>
          </name>
          <name>
            <surname>BunkÃ³czi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>VB</given-names>
          </name>
          <name>
            <surname>Davis</surname>
            <given-names>IW</given-names>
          </name>
          <name>
            <surname>Echols</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Headd</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Hung</surname>
            <given-names>LW</given-names>
          </name>
          <name>
            <surname>Kapral</surname>
            <given-names>GJ</given-names>
          </name>
          <name>
            <surname>Grosse-Kunstleve</surname>
            <given-names>RW</given-names>
          </name>
          <etal/>
          <article-title>PHENIX: a comprehensive Python-based system for macromolecular structure solution</article-title>
          <source>Acta Crystallogr D Biol Crystallogr</source>
          <year>2010</year>
          <volume>66</volume>
          <fpage>213</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="doi">10.1107/S0907444909052925</pub-id>
          <?supplied-pmid 20124702?>
          <pub-id pub-id-type="pmid">20124702</pub-id>
        </mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>

</metadata></record></GetRecord></OAI-PMH>